Skip to main content
. 2014 Mar 12;37(3):180–186. doi: 10.1097/CJI.0000000000000023

FIGURE 2.

FIGURE 2

Phenotypic analysis of myeloid cells in patient PBMCs. PBMCs from patients obtained at various timepoints were analyzed by flow cytometry for cells expressing CD33+CD11b+HLA-DRlow markers, consistent with a myeloid-derived suppressor cell phenotype. Data are presented as the percentage of cells staining positive for these markers.